SCHEMBL19919557

SCHEMBL19919557

Cc1cccc(-c2ccc3c4ccc(-c5cccc(C)c5)cc4n(-c4cc(C#N)c(-c5cc(C)nc(C)c5)cc4-n4c5cc(-c6cccc(C)c6)ccc5c5ccc(-c6cccc(C)c6)cc54)c3c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.41
LRRK2 Q5S007 3/20 0.37
KDM4A O75164 1/20 0.37
KDM5B Q9UGL1 1/20 0.37
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
IMPDH2 P12268 1/20 0.35
KMT2A Q03164 1/20 0.34
KDM4E B2RXH2 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MAPT P10636 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SCN9A Q15858 1/20 0.34
MAPK1 P28482 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913239 0.92 AR (0.40) ARLRRK2KDM4AKDM5BADORA2A
SCHEMBL19919637 0.91 KDM5B (0.35) KDM5B
SCHEMBL19919830 0.91 CYP1A2 (0.40) KDM4ECYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL22170399 0.90 AR (0.36) ARLRRK2KDM4AKDM5BADORA2A
SCHEMBL23487653 0.90 AR (0.40) ARLRRK2KDM4AKDM5BADORA2A
SCHEMBL19919813 0.90 ADORA2A (0.39) ARADORA2AKMT2ACYP1A2HIF1A
SCHEMBL19919834 0.90 AR (0.37) ARKDM4ENPSR1L3MBTL1SMN1; SMN2
SCHEMBL19913231 0.89 AR (0.38) ARLRRK2KDM4AKDM5BADORA2A
SCHEMBL19909139 0.88 MAOA (0.34) KDM4ECYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL19919639 0.88 GRIN1 (0.33) KDM5BIMPDH2KDM4ECYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 AR 4245/4885LRRK2 4345/4885KDM4A 4544/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 AR 4444/4885LRRK2 2809/4885KDM4A 3328/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 AR 4245/4885LRRK2 4345/4885KDM4A 4544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.